Biology subjects

Chanaday, N. L.

Publications and source records attributed to Chanaday, N. L..

5 recordsLinked to original sources

bioRxiv2026

Glycosyltransferases regulate the expression of Golgi phosphoprotein 3 (GOLPH3)

Glycosphingolipid glycosyltransferases (GGTs) can organize as multienzyme complexes localized along the Golgi complex. However, the influence of the relative presence of GGTs on the localization of their clients is unclear. Here, we determine that expression of certain full-length GGTs increases the levels of Golgi phosphoprotein 3 (GOLPH3), an adaptor oncoprotein involved in Golgi trafficking and organization. Furthermore, we demonstrate that expression of the N-terminal domain of GGTs, which lacks the catalytic domain, is sufficient to achieve this regulation on GOLPH3 in a cell type-dependent manner. We also identify the N-terminal domain of {beta}4GalT-VI GGT as an inhibitor of GOLPH3 expression and thus a potential therapeutic application, since GOLPH3 overexpression is associated with progression and poor prognosis of multiple tumor types. Our data further suggest that the cytoplasmic tail of {beta}4GalT-VI N-terminal domain interferes with the ability of GOLPH3 to interact with phosphatidylinositol 4-phosphate, which consequently reduces the levels of GOLPH3, thereby impairing its function in the acquisition of mesenchymal features.

cancer biology↗

bioRxiv2025

Sparse delivery of Synaptobrevin-2 to neurons using extracellular vesicles

Synaptobrevin-2 (Syb2) is an essential SNARE protein for neurotransmitter release and communication in the nervous system. We previously showed that Syb2 is also exchanged among neurons via extracellular vesicles (EVs). Host neurons can rapidly incorporate exogenous Syb2 into their synaptic vesicle cycle to support neurotransmitter release, however the endocytic mechanism of Syb2-containing EVs is unknown. Here, we use a fusion of Syb2 with the pH-sensitive GFP (Syb2-pHluorin) to track the incorporation of Syb2-containing EVs into neurons and the trafficking of exogenous Syb2 to synaptic vesicles at synapses. We determined that Syb2-containing EVs are endocytosed via Clathrin- and Dynamin-independent pathways. Moreover, Syb2-containing EVs are directly uptaken by axons and are rapidly incorporated into functional synaptic vesicles. These Syb2-pHluorin positive synaptic vesicles are endocytosed with either ultrafast (<1s) or fast ([~]1-3s) kinetics during synaptic transmission, suggesting limited diffusion and high fidelity in the fast retrieval of synaptic vesicle molecules immediately after fusion. This work introduces a novel application of EVs as vehicles to deliver fluorescent molecules in a neuron-specific, targeted manner to investigate protein transport mechanisms without overexpression artifacts. Our findings expand our understanding of the mechanisms EVs use to enter neurons.

cell biology↗

bioRxiv2025

Pseudouridine selects RNAs for extracellular transport

RNAs move through the extracellular space to transmit information between cells, including mammalian neurons, yet how specific RNAs are channeled into these extracellular routes is unknown. Using genome-wide CRISPR screening, proteomics, and high-sensitivity transcriptomics in a neuronal model system, we identify domesticated retroviral proteins and RNA-modifying enzymes that regulate RNA loading into and transportation via extracellular vesicles. We show that the pseudouridine synthase PUS1 is a key determinant of RNA trafficking, and that its catalytic product in RNA, pseudouridine, is enriched in extracellular RNAs from transformed and primary neurons. Furthermore, the presence of pseudouridine on select RNAs is both necessary and sufficient for their extracellular export. Finally, we show that myosin light chain 6 (MYL6) is a pseudouridine-binding protein required for secretion of synthetic and endogenous RNAs. These findings reveal a biochemical code linking chemical RNA modification to extracellular transport, and establish a framework to study the function of extracellular RNAs in the nervous system and beyond.

molecular biology↗

bioRxiv2025

Astrocytes mobilize a broader repertoire of lysosomal repair mechanisms than neurons

Lysosomal damage impairs proteostasis and contributes to neurodegenerative diseases, yet cell-type-specific differences in lysosomal repair remain unclear. Using a neuron-astrocyte coculture system, we compared responses to lysosomal injury induced by a lysosomotropic methyl ester. Both neurons and astrocytes showed lysosomal damage, marked by galectin-3 recruitment to lumenal lysosomal {beta}-galactosides, elevated lysosomal pH, and engagement of lysophagy receptors TAX1BP1 and p62. However, astrocytes showed a preferential recruitment of ESCRT repair machinery to damaged lysosomes. Additionally, the lysosomal membrane reformation pathway regulated by the RAB7-GAP, TBC1D15, was more robustly activated in astrocytes. By contrast, the PITT pathway, mediating lipid transfer between the ER and damaged lysosomes, was engaged in both cell types. Our data reveal a divergence in how neurons and astrocytes mobilize repair pathways to manage lysosomal damage. These data may reflect differences in lysosomal resilience between astrocytes and neurons and inform therapeutic strategies to correct lysosomal dysfunction in neurodegenerative diseases.

neuroscience↗

bioRxiv2025

Nanobinders for Synaptotagmin 1 enable the analysis of synapticvesicle dynamics in rodent and human models.

Synaptic neurotransmission is a critical hallmark of brain activity and one of the first processes to be affected in neural diseases. Monitoring this process, and in particular synaptic vesicle recycling, in living cells has been instrumental in unraveling mechanisms responsible for neurotransmitter release. However, currently available reporters suffer from major limitations such large probe size or lack of suitability for human neurons, hampering the understanding of human synaptic pathophysiology. Here we describe the NbLumSyt1 toolkit, a panel of nanobody-based affinity probes targeting the luminal domain of the synaptic vesicle protein Synaptotagmin 1 (Syt1). These new tools enable quantitative, non-invasive imaging and functional interrogation of synaptic transmission in human neurons, with unprecedented precision, versatility and cost efficiency, in technologies ranging from fixed-and live-cell super-resolution imaging to electron microscopy and mass spectrometry. Overall, NbLumSyt1 nanobinders provide a valuable platform for human synaptic physiology and pathophysiology, benefiting fundamental neuroscience and translational efforts to study and develop treatments for brain-related disorders.

neuroscience↗